Revolution Medicines, Inc.RVMDNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+58.3%
5Y CAGR+50.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+58.3%/yr
vs +48.4%/yr prior
5Y CAGR
+50.0%/yr
Recent acceleration
Acceleration
+9.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
7.6x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.17B | +69.1% |
| 2024 | $689.52M | +38.2% |
| 2023 | $498.76M | +69.8% |
| 2022 | $293.66M | +35.1% |
| 2021 | $217.40M | +41.5% |
| 2020 | $153.68M | +47.5% |
| 2019 | $104.16M | +72.2% |
| 2018 | $60.49M | +1231.6% |
| 2017 | $4.54M | - |